Chlamydia antigens

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/118 (2006.01)

Patent

CA 2754618

The invention provides identifies Chlamydia antigens for use in the treatment, prevention and/or diagnosis of Chlamydia infection. In particular, the invention provides antigens CT733, CT1 53, CT601, CT279, CT443, CT372, CT456, CT381, CT255, CT341, CT716, CT745, CT387, CT812, CT869, CT166, CT175, CT163, CT214, CT721, CT127, CT043, CT823 and/or CT600 from C. trachomatis for the treatment, prevention or diagnosis of Chlamydia infection.

L'invention porte sur des antigènes de chlamydia pour utilisation dans le traitement, la prévention et/ou le diagnostic d'une infection par la chlamydia. En particulier, l'invention porte sur les antigènes CT733, CTl 53, CT601, CT279, CT443, CT372, CT456, CT381, CT255, CT341, CT716, CT745, CT387, CT812, CT869, CT166, CT175, CT163, CT214, CT721, CT127, CT043, CT823 et/ou CT600 provenant de C trachomatis pour le traitement, la prévention ou le diagnostic d'une infection par la chlamydia.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Chlamydia antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chlamydia antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chlamydia antigens will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1800634

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.